Skip to main content

Table 2 Summary of Adverse Events. Numbers refer to the number of study patients experiencing an adverse event of a given grade

From: Phase-I trial of survivin inhibition with EZN-3042 in dogs with spontaneous lymphoma

 

VCOG-CTCAE v1.1 Grade

1

2

3

ALP Elevation

1

  

Anemia

2

  

AST Elevation

1

  

Creatinine Elevation

1

  

GGT Elevation

1

  

Hypercalcemia

1

  

Hypercholesterolemia

1

  

Hyperproteinemia

1

  

Hypochloremia

2

  

Hypokalemia

1

  

Hypomagnesemia

2

  

Lymphocytosis

1

  

Neutrophilia

3

  

Monocytosis

1

  

Proteinuria

1

  

Thrombocytopenia

  

1

  1. VCOG-CTCAE v1.1 Veterinary Co-operative Oncology Group Common Terminology Criteria for Adverse Events Following Antineoplastic Therapy v1.1. ALP Alkaline phosphatase. AST Aspartate aminotransferase, GGT Gamma-glutamyltransferase
Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us